Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic Cancer
Author:
Affiliation:
1. From the Department of Urology, Faculty of Medicine, Kyoto University, Kyoto, Japan
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference27 articles.
1. Purification of a human prostate specific antigen;Wang;Invest. Urol.,1979
2. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients;Stamey;J. Urol.,1989
3. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer;Ercole;J. Urol.,1987
4. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients;Stamey;J. Urol.,1989
5. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients;Stamey;J. Urol.,1989
Cited by 104 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world retrospective study of prostate-specific antigen and safety assessment with darolutamide plus androgen deprivation therapy for metastasis hormone-sensitive prostate cancer;Translational Andrology and Urology;2024-03
2. Prognostic significance of nadir PSA value and time to nadir PSA in patients with metastatic castration-naive prostate cancer receiving first-line hormonotherapy;Journal of Cancer Research and Therapeutics;2023-12-15
3. Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer;Annals of Oncology;2023-05
4. Validity and Future of Primary Androgen Deprivation Therapy in Prostate Cancer. Integration in the Era of New Agents Targeting the Androgen Receptor;Archivos Españoles de Urología;2023
5. Analysis of Risk Factors for Early Progression of Prostate Cancer After Initial Endocrine Therapy;Journal of Cancer;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3